Purpose Giant prolactinomas are a rare entity, representing approximately 5% of all
prolactinomas. A systematic review of 196 adult cases was performed. A comparison of the …

Introduction Aggressive prolactinomas (APRLs) pose a significant clinical challenge due to
their high rate of regrowth and potentially life-threatening complications. In this study, we …

Medulloblastoma is the most common pediatric embryonal brain tumor, and may occur in
cancer predisposition syndromes. We describe novel associations of medulloblastoma with …

Пролактиномы-наиболее распространенные гормонально-активные аденомы
гипофиза. В 20% случаев наблюдается резистентность к методу выбора их лечения …

Hyperprolactinemia is a very frequent cause for evaluation in daily medical practice, but only
some cases with significant and persistent hyperprolactinemia are related to a lactotroph …

Prolactinomas are the most common secreting adenomas of the pituitary. In 20% of cases
resistance to dopamine-agonists treatment is observed. Medical therapy resistance causes …

Background: The somatostatin analog, pasireotide, is used for the treatment of acromegaly
after the failure of surgery and/or first-line medical treatment. Case Presentation: A 48-year …

The priority treatment approach for prolactinomas is therapy with dopamine agonists, which
allows for elimination of clinical symptoms, normalization of prolactin levels, reduction of the …

Приоритетный метод лечения пролактином–медикаментозная терапия агонистами
дофамина, которая позволяет добиться устранения клинических симптомов …

The most common neoplastic change in the pituitary gland is a prolactinoma. Its presence
leads to an increase in prolactin levels in the body, known as hyperprolactinemia. This tumor …